128 related articles for article (PubMed ID: 9415533)
1. Alpha1-antichymotrypsin polymorphism in Japanese cases of Alzheimer's disease.
Yoshizawa T; Yamakawa-Kobayashi K; Hamaguchi H; Shoji S
J Neurol Sci; 1997 Nov; 152(2):136-9. PubMed ID: 9415533
[TBL] [Abstract][Full Text] [Related]
2. Alpha-antichymotrypsin gene polymorphism and risk for Alzheimer's disease in the Spanish population.
Ezquerra M; Blesa R; Tolosa E; Ballesta F; Oliva R
Neurosci Lett; 1998 Jan; 240(2):107-9. PubMed ID: 9486483
[TBL] [Abstract][Full Text] [Related]
3. No association between the alpha 1-antichymotrypsin A allele and Alzheimer's disease.
Murphy GM; Sullivan EV; Gallagher-Thompson D; Thompson LW; van Duijn CM; Forno LS; Ellis WG; Jagust WJ; Yesavage J; Tinklenberg JR
Neurology; 1997 May; 48(5):1313-6. PubMed ID: 9153464
[TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein E and alpha1-antichymotrypsin polymorphism in Alzheimer's disease.
Nacmias B; Tedde A; Latorraca S; Piacentini S; Bracco L; Amaducci L; Guarnieri BM; Petruzzi C; Ortenzi L; Sorbi S
Ann Neurol; 1996 Oct; 40(4):678-80. PubMed ID: 8871590
[TBL] [Abstract][Full Text] [Related]
5. No association between alpha1-antichymotrypsin polymorphism, apolipoprotein E and patients with late-onset Alzheimer's disease.
Helisalmi S; Mannermaa A; Lehtovirta M; Ryynänen M; Riekkinen P; Soininen H
Neurosci Lett; 1997 Aug; 231(1):56-8. PubMed ID: 9280167
[TBL] [Abstract][Full Text] [Related]
6. No effect of the alpha1-antichymotrypsin A allele in Alzheimer's disease.
Didierjean O; Martinez M; Campion D; Hannequin D; Dubois B; Martin C; Puel M; Thomas Anterion C; Pasquier F; Moreau O; Babron MC; Penet C; Agid Y; Clerget-Darpoux F; Frebourg T; Brice A
J Neurol Neurosurg Psychiatry; 1997 Jul; 63(1):103-5. PubMed ID: 9221977
[TBL] [Abstract][Full Text] [Related]
7. Genetic risk factors in Japanese Alzheimer's disease patients: alpha1-ACT, VLDLR, and ApoE.
Yamanaka H; Kamimura K; Tanahashi H; Takahashi K; Asada T; Tabira T
Neurobiol Aging; 1998; 19(1 Suppl):S43-6. PubMed ID: 9562467
[TBL] [Abstract][Full Text] [Related]
8. Alpha-1-antichymotrypsin gene polymorphism and risk for sporadic Alzheimer's disease in a German population.
Schwab SG; Bagli M; Papassotiropoulos A; Jessen F; Maier W; Rao ML; Heun R
Dement Geriatr Cogn Disord; 1999; 10(6):469-72. PubMed ID: 10559561
[TBL] [Abstract][Full Text] [Related]
9. Association between ACT polymorphism and Alzheimer's disease.
Kamboh MI; Aston CE; Dekosky ST
Neurology; 1998 Feb; 50(2):574-6. PubMed ID: 9508644
[No Abstract] [Full Text] [Related]
10. [ACT/AA polymorphism could duplicate the APOE*epsilon4-associated Alzheimer's disease risk].
Hernández-Charro B; Moreno S; Valiente A; Manubens JM; Villar MD; Ramos-Arroyo MA
Med Clin (Barc); 2004 Sep; 123(7):251-4. PubMed ID: 15482730
[TBL] [Abstract][Full Text] [Related]
11. Implication of alpha1-antichymotrypsin polymorphism in familial Alzheimer's disease.
Nacmias B; Marcon G; Tedde A; Forleo P; Latorraca S; Piacentini S; Amaducci L; Sorbi S
Neurosci Lett; 1998 Mar; 244(2):85-8. PubMed ID: 9572591
[TBL] [Abstract][Full Text] [Related]
12. [The relation between alpha1-antichymotrypsin gene polymorphism and epsilon4 allele of apolipoprotein E gene in Alzheimer disease in Chinese].
Tang G; Jiang S; Gu N; Jin T; Lin S; Qian Y; Wang D; Zhang M
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 1999 Apr; 16(2):94-6. PubMed ID: 10194255
[TBL] [Abstract][Full Text] [Related]
13. Absence of association of alpha1-antichymotrypsin polymorphisms with Alzheimer's disease: a report on autopsy-confirmed cases.
Itabashi S; Arai H; Matsui T; Matsushita S; Muramatsu T; Higuchi S; Trojanowski JQ; Sasaki H
Exp Neurol; 1998 Jun; 151(2):237-40. PubMed ID: 9628759
[TBL] [Abstract][Full Text] [Related]
14. Microsatellite polymorphism of the alpha 1-antichymotrypsin gene locus associated with sporadic Alzheimer's disease.
Morgan K; Morgan L; Carpenter K; Lowe J; Lam L; Cave S; Xuereb J; Wischik C; Harrington C; Kalsheker NA
Hum Genet; 1997 Jan; 99(1):27-31. PubMed ID: 9003488
[TBL] [Abstract][Full Text] [Related]
15. Polygenic determinants of Alzheimer's disease: modulation of the risk by alpha-1-antichymotrypsin.
DeKosky ST; Aston CE; Kamboh MI
Ann N Y Acad Sci; 1996 Dec; 802():27-34. PubMed ID: 8993481
[TBL] [Abstract][Full Text] [Related]
16. APOE*4-associated Alzheimer's disease risk is modified by alpha 1-antichymotrypsin polymorphism.
Kamboh MI; Sanghera DK; Ferrell RE; DeKosky ST
Nat Genet; 1995 Aug; 10(4):486-8. PubMed ID: 7670501
[TBL] [Abstract][Full Text] [Related]
17. Alpha 1-antichymotrypsin gene polymorphism and risk for Alzheimer's disease.
Muramatsu T; Matsushita S; Arai H; Sasaki H; Higuchi S
J Neural Transm (Vienna); 1996; 103(10):1205-10. PubMed ID: 9013407
[TBL] [Abstract][Full Text] [Related]
18. Lack of genetic associations of alpha-1-antichymotrypsin polymorphism with alzheimer-type neuropathological changes or sporadic Alzheimer's disease.
Sodeyama N; Yamada M; Itoh Y; Suematsu N; Matsushita M; Otomo E; Mizusawa H
Dement Geriatr Cogn Disord; 1999; 10(3):221-5. PubMed ID: 10325450
[TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein E and alpha-1-antichymotrypsin allele polymorphism in sporadic and familial Alzheimer's disease.
Licastro F; Pedrini S; Govoni M; Pession A; Ferri C; Annoni G; Casadei V; Veglia F; Bertolini S; Grimaldi LM
Neurosci Lett; 1999 Aug; 270(3):129-32. PubMed ID: 10462111
[TBL] [Abstract][Full Text] [Related]
20. Apolipoprotein E and alpha-1 antichymotrypsin polymorphism genotyping in Alzheimer's disease and in dementia with Lewy bodies. Distinctions between diseases.
Lamb H; Christie J; Singleton AB; Leake A; Perry RH; Ince PG; McKeith IG; Melton LM; Edwardson JA; Morris CM
Neurology; 1998 Feb; 50(2):388-91. PubMed ID: 9484359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]